about
Breast MRI: EUSOBI recommendations for women's informationNovel TPM3 mutation in a family with cap myopathy and review of the literature.Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.Brain tumors: full- and half-dose contrast-enhanced MR imaging at 3.0 T compared with 1.5 T--Initial Experience.3.0 T neuroimaging: technical considerations and clinical applications.Current status of breast MR imaging. Part 2. Clinical applications.Whole-body high-field-strength (3.0-T) MR Imaging in Clinical Practice. Part I. Technical considerations and clinical applications.Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, FraSensitivity encoding for diffusion-weighted MR imaging at 3.0 T: intraindividual comparative study.Bridging the integration gap between imaging and information systems: a uniform data concept for content-based image retrieval in computer-aided diagnosis.MRI-based attenuation correction for hybrid PET/MRI systems: a 4-class tissue segmentation technique using a combined ultrashort-echo-time/Dixon MRI sequence.A Rare Complication Following Breast Implant Surgery: Capsular Contracture with a Cutaneous Silicone Fistula after Breast Reconstruction with Silicone Gel Implants.The use of contrast-enhanced post Mortem CT in the detection of cardiovascular deaths.Influence of trigger type, tube voltage and heart rate on calcified plaque imaging in dual source cardiac computed tomography: phantom study.Diagnostic accuracy of diffusion-weighted magnetic resonance imaging versus positron emission tomography/computed tomography for early response assessment of liver metastases to Y90-radioembolization.In vivo MRI visualization of mesh shrinkage using surgical implants loaded with superparamagnetic iron oxidesAcute and subacute ischemic stroke at high-field-strength (3.0-T) diffusion-weighted MR imaging: intraindividual comparative study.Positive Contrast MRI Techniques for Visualization of Iron-Loaded Hernia Mesh Implants in PatientsCorrection: Positive Contrast MRI Techniques for Visualization of Iron-Loaded Hernia Mesh Implants in PatientsThe Changing World of Breast Cancer: A Radiologist's Perspective.Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial.Dynamic contrast-enhanced breast MR imaging in men: preliminary results.Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience.The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?High-field-strength MR imaging of the liver at 3.0 T: intraindividual comparative study with MR imaging at 1.5 T.Female pelvis: MR imaging at 3.0 T with sensitivity encoding and flip-angle sweep technique.Concepts for differential diagnosis in breast MR imaging.MR imaging for surveillance of women at high familial risk for breast cancer.Intra-individual comparison of image contrast in SPIO-enhanced liver MRI at 1.5T and 3.0T.The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice.Intracranial aneurysms: role of multidetector CT angiography in diagnosis and endovascular therapy planning.Pre-operative staging of breast cancer with breast MRI: one step forward, two steps back?Black box integration of computer-aided diagnosis into PACS deserves a second chance: results of a usability study concerning bone age assessment.Magnetic Resonance Imaging Findings After Percutaneous Irreversible Electroporation of Liver Metastases: A Systematic Longitudinal StudyThe significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment.Dual-source parallel radiofrequency excitation body MR imaging compared with standard MR imaging at 3.0 T: initial clinical experience.Liver dysplasia: US molecular imaging with targeted contrast agent enables early assessment.Effects of tamoxifen and aromatase inhibitors on breast tissue enhancement in dynamic contrast-enhanced breast MR imaging: a longitudinal intraindividual cohort study.
P50
Q27323080-74EAF009-DB74-496D-B59E-3912EDA02899Q30696059-8C2D4568-2A8D-484A-A25A-1751E80989E8Q30981151-20EE2AFB-EC08-4F33-A6C8-970FD0A4F980Q31012336-3C2BDB76-0B91-45C5-B351-6F83D7AECA3DQ31042454-71E42802-6CC8-4E26-A8E3-764F463B1403Q31122216-6FB3FADE-5CEF-4758-AE40-FC9A7FE67F7DQ31148102-A660DE04-3029-4E5A-B84D-09FE6FAD40ADQ32186742-8C248927-ADB1-48E1-925F-653CFA241DE7Q33211201-64AFC7F3-CADF-4B00-8A2D-F53DB3FAF19CQ33932516-D14E193F-A34E-4BB6-8BB8-C1D39E651E46Q34233331-6A121867-3C81-4C25-AA69-3454F6189B8DQ34870310-5642EE2F-C95A-44A7-9010-0971520B46E9Q35156073-BDAAE7AF-9C77-42BA-ACD3-BD2F163E7181Q35236323-3F767DB4-BFAD-46F1-BBEF-88C3A464E57DQ35570801-195236DB-A2E6-4B95-9219-ABD479951F29Q35892670-9B7AD7EF-5431-454A-BA36-740285142908Q35985770-D7A50694-4709-4A28-9AC8-902B31CC32FEQ36021193-4DF619D7-C218-4322-8B6E-E7C8F2D692E6Q36138231-9C9DF86E-FA18-4846-AA18-31A881B65ADDQ36217490-62CB7CCA-FCD5-4175-9B89-E4E89A3F9D61Q36238933-3BB2ED7C-D4FB-44A4-9187-50C004D17A40Q36265703-1CF7F0A4-9FCF-4061-AD49-F763CCE940A8Q36350045-9399273E-6C75-4F73-9788-C8245A89602FQ36350990-EDA2FB5A-5E07-40E0-BB55-B7441D479115Q36426475-43193D1A-7CB5-48A0-9C33-58ECC5143D22Q36550846-9477DB0A-11D5-4B32-9C0E-76CB97C3E182Q36565527-A754B650-E0AB-4734-8A75-FE384AB9A345Q36597129-E979CDB4-15D9-4D12-B5D7-FE1764F7A540Q36650595-03835880-AF64-47EB-B678-D3E5B1A033E0Q36650626-90E85F8C-410E-49D8-8DA8-A205355637CDQ36685129-61818F8E-94F8-42A2-A070-F25FFC21B4C1Q36886780-69854E0D-7692-4EBD-AEED-8B5A1361BDDEQ36886819-9B666F31-11C1-4B4B-86EF-064B97DFA785Q36980989-50998C73-1A69-4D18-91F1-681A09451E3BQ36993039-B77FAD70-99F0-4792-BBBB-AD0C7A9DEC42Q37486098-873FA8DD-B4DB-42B0-948C-BE4A4080A67AQ37775809-B91F43B7-10A2-47B7-8A6D-BB9219756C66Q37780896-E4A78D62-53F0-4698-A912-82294EEDD0C2Q38077605-33D2347F-E015-419D-8AA9-6284E096E934Q38183074-98D241BF-1490-4BD6-881D-2C0E7164AF8E
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Christiane Kuhl
@ast
Christiane Kuhl
@en
Christiane Kuhl
@es
Christiane Kuhl
@nl
type
label
Christiane Kuhl
@ast
Christiane Kuhl
@en
Christiane Kuhl
@es
Christiane Kuhl
@nl
prefLabel
Christiane Kuhl
@ast
Christiane Kuhl
@en
Christiane Kuhl
@es
Christiane Kuhl
@nl
P106
P1153
7006785400
P21
P2456
P31
P496
0000-0001-8696-2363